» Articles » PMID: 36380478

Late-effect Awareness and Follow-up of Cancer in General Practice

Overview
Specialty Public Health
Date 2022 Nov 16
PMID 36380478
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: With increasing cancer incidence and survival rates, follow-up care becomes a major healthcare concern, placing increased demands on general practitioners (GPs). We explored GPs' awareness of late effects (LEs) after cancer treatment. Their degree of involvement and attitudes towards follow-up care was studied separately for solid cancers and Hodgkin's lymphoma (HL).

Design And Setting: Mailed questionnaire study in Norwegian general practice.

Subjects: 185 responding GPs with responsibility for HL survivors, more than 10 years since diagnosis.

Main Outcome Measures And Results: All GPs reported some awareness of LEs. Increasing awareness of LEs was associated with female sex, being a specialist, having experience from hospital-based cancer care and familiarity with official guidelines on LEs after treatment. The majority of GPs were involved in follow-up care, which increased with patients' time since treatment and was associated with higher awareness of LEs. GPs with work experience in hospital-based cancer care were more likely to be engaged in HL follow-up. Most GPs were willing to provide follow-up care at some point after treatment. Older and more experienced GPs, and those satisfied with the collaboration with hospital specialists, were more likely to provide follow-up earlier.

Conclusion: GPs' awareness of LEs and their willingness to provide follow-up care were related to familiarity with guidelines and experience. GPs more involved in follow-up care also had higher knowledge of LEs. Distribution of guidelines on LEs and follow-up care, and improving collaboration with hospital specialists, might increase GPs' knowledge and willingness to become involved in follow-up care, especially early in their careers. GPs' involvement and attitude towards follow-up of survivors of common solid cancers and HL, a rare malignant disease, were similar.KEY POINTSNorwegian general practitioners (GPs) are involved in survivorship care after cancer treatment. We investigated their awareness of late effects (LEs), their involvement and their attitude towards follow-up care of solid cancers and Hodgkin's lymphoma. • GPs registered as specialists, aware of guidelines and with experience from hospital-based cancer care reported higher awareness of LEs.  • GPs with higher awareness of LEs were more frequently involved in follow-up care.  • GPs with longer experience in general practice were comfortable with follow-up care at an earlier stage after treatment.  • Results were similar for follow-up care of survivors of solid cancers and Hodgkin's lymphoma.

Citing Articles

Knowledge, attitudes, and practices regarding whole-course management among patients with gastrointestinal cancers: a cross-sectional study.

Huang M, Feng L, Ren H, Yuan Z, Liu C, Liu Y World J Surg Oncol. 2025; 23(1):45.

PMID: 39924482 PMC: 11809093. DOI: 10.1186/s12957-025-03668-7.


Outcomes of guidelines from health technology assessment organizations in community-based primary care: a systematic mixed studies review.

Baradaran A, Tolentino R, Grad R, Ganache I, Gore G, Abbasgholizadeh Rahimi S Int J Technol Assess Health Care. 2024; 40(1):e56.

PMID: 39539094 PMC: 11579698. DOI: 10.1017/S0266462324000370.

References
1.
Eikeland S, Smeland K, Mols F, Fagerli U, Bersvendsen H, Kiserud C . Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin's lymphoma; symptom burden and quality of life. Acta Oncol. 2021; 60(7):911-920. DOI: 10.1080/0284186X.2021.1917776. View

2.
Bigenwald C, Galimard J, Quero L, Cabannes-Hamy A, Thieblemont C, Boissel N . Hodgkin lymphoma in adolescent and young adults: insights from an adult tertiary single-center cohort of 349 patients. Oncotarget. 2017; 8(45):80073-80082. PMC: 5668122. DOI: 10.18632/oncotarget.20684. View

3.
Nekhlyudov L, OMalley D, Hudson S . Integrating primary care providers in the care of cancer survivors: gaps in evidence and future opportunities. Lancet Oncol. 2017; 18(1):e30-e38. PMC: 5553291. DOI: 10.1016/S1470-2045(16)30570-8. View

4.
Ng A . Current survivorship recommendations for patients with Hodgkin lymphoma: focus on late effects. Blood. 2014; 124(23):3373-9. DOI: 10.1182/blood-2014-05-579193. View

5.
Austad B, Hetlevik I, Mjolstad B, Helvik A . Applying clinical guidelines in general practice: a qualitative study of potential complications. BMC Fam Pract. 2016; 17:92. PMC: 4957916. DOI: 10.1186/s12875-016-0490-3. View